• LAST PRICE
    1.5900
  • TODAY'S CHANGE (%)
    Trending Down-0.0200 (-1.2422%)
  • Bid / Lots
    1.5800/ 2
  • Ask / Lots
    1.5900/ 21
  • Open / Previous Close
    1.6000 / 1.6100
  • Day Range
    Low 1.5800
    High 1.7000
  • 52 Week Range
    Low 0.9001
    High 16.9000
  • Volume
    654,736
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 1.61
TimeVolumeSCLX
09:32 ET36401.62
09:34 ET108901.6175
09:36 ET70911.625
09:38 ET1001.625
09:39 ET18371.625
09:43 ET47501.64
09:45 ET47081.6302
09:48 ET19301.6309
09:50 ET170501.6183
09:52 ET18501.59
09:57 ET7181.59
10:01 ET15221.595
10:03 ET9401.6
10:06 ET10001.6
10:08 ET1001.595
10:10 ET1261.595
10:12 ET3761.5999
10:14 ET11991.6
10:15 ET1001.59
10:17 ET75151.595
10:19 ET42001.61
10:21 ET562021.65
10:24 ET14701.6492
10:26 ET13201.645
10:28 ET3481.645
10:32 ET18901.645
10:35 ET119991.65
10:37 ET10671.65
10:44 ET2001.65
10:46 ET2001.6478
10:48 ET5001.645
10:50 ET488131.68
10:51 ET193901.695
10:53 ET423731.675
10:55 ET25231.67
10:57 ET73361.655
11:00 ET3201.6501
11:02 ET22001.6502
11:06 ET8001.66
11:09 ET2001.66
11:18 ET12001.655
11:26 ET2231.6599
11:29 ET2001.66
11:38 ET5001.655
11:47 ET9231.66
11:49 ET6001.665
11:51 ET10001.665
12:00 ET4501.6699
12:02 ET8931.66
12:07 ET11761.675
12:16 ET4001.68
12:18 ET1001.69
12:21 ET20831.6987
12:23 ET142671.68
12:25 ET5001.685
12:27 ET7501.68
12:30 ET3051.685
12:32 ET2001.68
12:34 ET45891.67
12:38 ET39551.67
12:43 ET1001.66
12:57 ET2001.665
12:59 ET1901.665
01:01 ET68151.66
01:06 ET23001.66
01:10 ET2001.67
01:12 ET68981.655
01:15 ET2001.6515
01:17 ET4501.6508
01:21 ET4001.65
01:28 ET1001.655
01:32 ET1001.65
01:35 ET14971.65
01:37 ET70001.64
01:39 ET4001.635
01:42 ET1011.635
01:48 ET1001.635
01:55 ET3001.635
01:57 ET5831.634
02:00 ET1001.635
02:02 ET1001.635
02:04 ET137521.63
02:06 ET1001.63
02:08 ET5001.6211
02:09 ET19281.6352
02:11 ET5051.6392
02:13 ET11001.63
02:15 ET54001.635
02:18 ET1041.635
02:20 ET58981.6254
02:22 ET122061.615
02:27 ET10061.615
02:29 ET2001.615
02:31 ET1081.615
02:33 ET3331.615
02:36 ET18601.615
02:38 ET3081.61
02:42 ET10061.615
02:45 ET1001.62
02:47 ET1121.615
02:49 ET24811.62
02:51 ET5111.63
02:54 ET6001.625
02:58 ET19091.625
03:00 ET3001.625
03:02 ET29471.625
03:03 ET20011.625
03:05 ET65241.615
03:07 ET6031.615
03:09 ET3001.615
03:12 ET11761.615
03:14 ET7001.61
03:16 ET67101.605
03:18 ET12591.605
03:20 ET14971.6
03:21 ET25381.6099
03:23 ET7621.6
03:25 ET29691.6
03:27 ET13431.6
03:30 ET44621.6
03:32 ET14561.6
03:34 ET6001.6
03:36 ET12001.6
03:38 ET17811.6
03:39 ET9001.6
03:41 ET286651.59
03:43 ET17621.59
03:45 ET13911.591
03:48 ET10591.59
03:50 ET32551.595
03:52 ET24891.59
03:54 ET240641.59
03:56 ET106631.59
03:57 ET73561.59
03:59 ET791651.59
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSCLX
Scilex Holding Co
264.2M
-1.3x
---
United StatesELTP
Elite Pharmaceuticals Inc
157.1M
10.1x
---
United StatesZVRA
Zevra Therapeutics Inc
240.6M
-5.0x
---
United StatesETON
Eton Pharmaceuticals Inc
96.3M
-96.4x
---
United StatesCRMD
CorMedix Inc
233.1M
-4.6x
---
United StatesDBVT
Dbv Technologies SA
139.0M
-2.0x
---
As of 2024-03-29

Company Information

Scilex Holding Company is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system) 1.8%, is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It also focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. Its second commercial product ELYXYB, is a potential first-line treatment, ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults. Its product candidates include SP-102 (SEMDEXA), SP-103 and SP-104. SP-102 is a viscous gel formulation of a used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica. Its SP-103 is a triple-strength formulation of ZTlido, for the treatment of chronic neck pain.

Contact Information

Headquarters
960 San Antonio RoadPALO ALTO, CA, United States 94303
Phone
650-516-4310
Fax
302-636-5454

Executives

Executive Chairman of the Board
Henry Ji
President, Chief Executive Officer, Director
Jaisim Shah
Chief Financial Officer, Senior Vice President, Company Secretary
Stephen Ma
Director
Jay Chun
Director
Yue Wu

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$264.2M
Revenue (TTM)
$46.7M
Shares Outstanding
166.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.25
Book Value
$-1.73
P/E Ratio
-1.3x
Price/Sales (TTM)
5.7
Price/Cash Flow (TTM)
---
Operating Margin
-225.55%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.